TRIB1 and acute promyelocytic leukemia: While the regulation of retinoic acid signalling has implications across cancer types, the putative role of TRIB1 in ATRA resistance is particularly relevant in AML and APL, where ATRA is commonly used to drive cell differentiation as part of treatment.